Report Detail
Global (United States, European Union and China) Combined hormonal contraceptive Market Research Report 2019-2025
- RnM3674477 |
- 16 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Combined hormonal contraceptive basically made by a combination of an estrogen and a progestogen which are primarily used to prevent unwanted pregnancies. Combined hormonal contraceptives are one of the effective contraceptives in modern medicine. Since late 1950s variety of innovation has been developed to improve the efficacy and safety of combined hormonal contraceptive. The trends have been shifted towards less androgenic progestogens and lower doses of estrogen and progestogen. Changing in drug doses and modification in drug component with the incorporation of new technologies that can reduce the risk factor and the continuing development of novel delivery systems that can be helpful to fulfill unmet needs of the market. The other health benefits of combined hormonal contraceptives include they reduce the risk of iron deficiency anemia, endometriosis, used in treating acne vulgaris, irregular menstrual flow, and polycystic ovarian syndrome. The mechanism of combined hormonal contraceptive is inhibition of follicle stimulating hormone and luteinizing hormone. Ethinylestradiol is the most common estrogen used in combined hormonal contraceptives, whereas other hormones are also used. The combined hormonal contraceptive products are available in various forms whereas pills have the maximum share in the combined hormonal contraceptive market. According to the Association of Women Health, around 100 million women use combined hormonal contraceptives throughout the world.
The growth of the combined hormonal contraceptive market is driven by growing predominance and more productive medications with emerging interest in quick substitutes. Reduction in the cost of hospitalization and high efficacy can be the prime driving factors for the growth of the combined hormonal contraceptive market over the forecast period. In emerging countries, the adoption of combined hormonal contraceptives has increased, along with increasing health consciousness and awareness. Growing menstruating population worldwide and various initiatives taken by the governments, such as birth control and women health awareness programs, are factors expected to increase the usage of combined hormonal contraceptive products globally. Strategic collaborations and acquisitions among manufacturers are also expected to boost the growth of the combined hormonal contraceptive market. However, side effects related to the combined hormonal contraceptive products can hamper the growth of the combined hormonal contraceptive market.
In 2019, the market size of Combined hormonal contraceptive is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Combined hormonal contraceptive.
This report studies the global market size of Combined hormonal contraceptive, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Combined hormonal contraceptive sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Teva Pharmaceutical Industries
Bayer HealthCare Pharmaceuticals
Actavis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Watson Pharma
Cipla
Novartis International
Market Segment by Product Type
Pills
Patch
Ring
Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-commerce
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Combined hormonal contraceptive status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Combined hormonal contraceptive manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Combined hormonal contraceptive are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Combined hormonal contraceptive Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Pills
- 1.3.3 Patch
- 1.3.4 Ring
- 1.4 Market Segment by Application
- 1.4.1 Global Combined hormonal contraceptive Market Share by Application (2019-2025)
- 1.4.2 Hospital Pharmacies
- 1.4.3 Retail Pharmacies
- 1.4.4 E-commerce
- 1.4.5 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Combined hormonal contraceptive Market Size
- 2.1.1 Global Combined hormonal contraceptive Revenue 2014-2025
- 2.1.2 Global Combined hormonal contraceptive Sales 2014-2025
- 2.2 Combined hormonal contraceptive Growth Rate by Regions
- 2.2.1 Global Combined hormonal contraceptive Sales by Regions 2014-2019
- 2.2.2 Global Combined hormonal contraceptive Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Combined hormonal contraceptive Sales by Manufacturers
- 3.1.1 Combined hormonal contraceptive Sales by Manufacturers 2014-2019
- 3.1.2 Combined hormonal contraceptive Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Combined hormonal contraceptive Revenue by Manufacturers (2014-2019)
- 3.2.2 Combined hormonal contraceptive Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Combined hormonal contraceptive Market Concentration Ratio (CR5 and HHI)
- 3.3 Combined hormonal contraceptive Price by Manufacturers
- 3.4 Key Manufacturers Combined hormonal contraceptive Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Combined hormonal contraceptive Market
- 3.6 Key Manufacturers Combined hormonal contraceptive Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Pills Sales and Revenue (2014-2019)
- 4.1.2 Patch Sales and Revenue (2014-2019)
- 4.1.3 Ring Sales and Revenue (2014-2019)
- 4.2 Global Combined hormonal contraceptive Sales Market Share by Type
- 4.3 Global Combined hormonal contraceptive Revenue Market Share by Type
- 4.4 Combined hormonal contraceptive Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Combined hormonal contraceptive Sales by Application
6 United States
- 6.1 United States Combined hormonal contraceptive Breakdown Data by Company
- 6.2 United States Combined hormonal contraceptive Breakdown Data by Type
- 6.3 United States Combined hormonal contraceptive Breakdown Data by Application
7 European Union
- 7.1 European Union Combined hormonal contraceptive Breakdown Data by Company
- 7.2 European Union Combined hormonal contraceptive Breakdown Data by Type
- 7.3 European Union Combined hormonal contraceptive Breakdown Data by Application
8 China
- 8.1 China Combined hormonal contraceptive Breakdown Data by Company
- 8.2 China Combined hormonal contraceptive Breakdown Data by Type
- 8.3 China Combined hormonal contraceptive Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Combined hormonal contraceptive Breakdown Data by Company
- 9.2 Rest of World Combined hormonal contraceptive Breakdown Data by Type
- 9.3 Rest of World Combined hormonal contraceptive Breakdown Data by Application
- 9.4 Rest of World Combined hormonal contraceptive Breakdown Data by Countries
- 9.4.1 Rest of World Combined hormonal contraceptive Sales by Countries
- 9.4.2 Rest of World Combined hormonal contraceptive Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Teva Pharmaceutical Industries
- 10.1.1 Teva Pharmaceutical Industries Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
- 10.1.4 Combined hormonal contraceptive Product Introduction
- 10.1.5 Teva Pharmaceutical Industries Recent Development
- 10.2 Bayer HealthCare Pharmaceuticals
- 10.2.1 Bayer HealthCare Pharmaceuticals Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
- 10.2.4 Combined hormonal contraceptive Product Introduction
- 10.2.5 Bayer HealthCare Pharmaceuticals Recent Development
- 10.3 Actavis
- 10.3.1 Actavis Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
- 10.3.4 Combined hormonal contraceptive Product Introduction
- 10.3.5 Actavis Recent Development
- 10.4 Pfizer
- 10.4.1 Pfizer Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
- 10.4.4 Combined hormonal contraceptive Product Introduction
- 10.4.5 Pfizer Recent Development
- 10.5 Johnson & Johnson
- 10.5.1 Johnson & Johnson Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
- 10.5.4 Combined hormonal contraceptive Product Introduction
- 10.5.5 Johnson & Johnson Recent Development
- 10.6 GlaxoSmithKline
- 10.6.1 GlaxoSmithKline Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
- 10.6.4 Combined hormonal contraceptive Product Introduction
- 10.6.5 GlaxoSmithKline Recent Development
- 10.7 Watson Pharma
- 10.7.1 Watson Pharma Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
- 10.7.4 Combined hormonal contraceptive Product Introduction
- 10.7.5 Watson Pharma Recent Development
- 10.8 Cipla
- 10.8.1 Cipla Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
- 10.8.4 Combined hormonal contraceptive Product Introduction
- 10.8.5 Cipla Recent Development
- 10.9 Novartis International
- 10.9.1 Novartis International Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
- 10.9.4 Combined hormonal contraceptive Product Introduction
- 10.9.5 Novartis International Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Combined hormonal contraceptive Sales Channels
- 11.2.2 Combined hormonal contraceptive Distributors
- 11.3 Combined hormonal contraceptive Customers
12 Market Forecast
- 12.1 Global Combined hormonal contraceptive Sales and Revenue Forecast 2019-2025
- 12.2 Global Combined hormonal contraceptive Sales Forecast by Type
- 12.3 Global Combined hormonal contraceptive Sales Forecast by Application
- 12.4 Combined hormonal contraceptive Forecast by Regions
- 12.4.1 Global Combined hormonal contraceptive Sales Forecast by Regions 2019-2025
- 12.4.2 Global Combined hormonal contraceptive Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Combined hormonal contraceptive. Industry analysis & Market Report on Combined hormonal contraceptive is a syndicated market report, published as Global (United States, European Union and China) Combined hormonal contraceptive Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Combined hormonal contraceptive market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
